Inhibition of liver cancer by the use of GnRH and GnRH analogs

Details Inhibition of liver cancer by the use of GnRH and GnRH analogs Inhibition of liver cancer by the use of GnRH and GnRH analogs

1994-05-13

1998-06-02

Russel, Jeffrey E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

435 723, 435 34, 436 64, 436813, 530313, 930130, A61K 3809, C07K 723, C12Q 104, G01N 33574

Patent

active

057600007

ABSTRACT:
The invention provides a method for treating liver cancer in a mammal comprising administering to the mammal an inhibitory effective amount of at least one GnRH-related compound. Pharmaceutical preparations useful for the treatment of liver cancer comprising an inhibitory effective amount of at least one GnRH-related compound and a pharmaceutically acceptable carrier are also provided. A further aspect of the invention provides a method for diagnosing liver cancer by determining the presence of receptors for GnRH on a biological sample.

REFERENCES:
patent: 4410514 (1983-10-01), Vale, Jr. et al.
patent: 4760053 (1988-07-01), Labrie
patent: 4820641 (1989-04-01), Nakanishi et al.
patent: 5091367 (1992-02-01), Konig et al.
patent: 5378688 (1995-01-01), Nett et al.
patent: 5411943 (1995-05-01), Bogden
Bogerd et al, Two Gonadotropin-Releasing Hormones From African Catfish. Biochem. Biophys. Res. Comm. 1992, vol. 187, No. 1, pp. 127-134.
Sherwood et al, Characterization of a teleost gonadotropin-releasing hormone. PNAS. May 1983, vol. 80, pp. 2794-2798.
American Chemical Society, 200th ACS National Meeting, Abstracts of Papers Part 1, issued 1990, Gombotz et al, "The Use of Controlled Release Devices In Commercial", Abstract AGRO 17.
Endocrinology, vol. 132, No. 3, issued 1993, Sower et al, "Primary Structure and Biological Activity of a . . . ", pp. 1125-1131.
Eur. J. Clin. Oncol., vol. 25, No. 9, issued 1989, Falkson et al, "Phase II Trial of Buserelin in Hepatocellular Carcinoma", pp. 1339-1340.
The Merck Index, 11th ed., published 1989 by Mercke Co., Inc. (Rahway), p. 229.
Lindhe et al., "Effects of Neonatal and Adult Castration and of Testosterone Substitution in Male Rats on Growth and Enzyme-altered Hepatic Foci in the Resistant Hepatocyte Model", Cancer Research 50: 2679-2682 (1990).
International Search Report, PCT IB95/00323, issued 28 Jul. 1995.
Eidne, Karin A., et al., "Gonadotropin-Releasing Hormone Binding Sites in Human Breast Carcinoma", Science 229: 989-991 (1995).
Forbes, Alastair, et al., "Response to Cyproterone Acetate Treatment in Primary Hepatocellular Carcinoma is Related to Fall in Free 5.alpha.-Dihydrotestosterone", Eur J Cancer Clin Oncol 23(11):1659-64 (1987).
Guechot, Jerome, et al., "Effect of D-Tryptophan-6-Luteinizing Hormone-Releasing Hormone on the Tumoral Growth and Plasma Sex Steroid Levels in Cirrhotic Patients with Hepatocellular Carcinoma", Hepatology 10(3):346-8 (1989).
Matsuura, Bunzo, et al., "Effect of antiandrogen treatment on chemical hepatocarcinogenesis in rats", J. Hepatol 21(2), 187-93 (1994).
Miller, W. R., et al., "Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist", 313: 231-33 (1985). Nature.
A. DeLean et al., "Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves," Am. J. Physiol., 235:E97-E102 (1978).
K.A. Eidne et al., "Gonadotropin-Releasing Hormone Binding Sites in Human Breast Carcinoma," Science, 229:989-991 (1985).
M. Fekete et al., "Receptors for Luteinizing Hormone-Releasing Hormone, Somatostatin, Prolactin, and Epidermal Growth Factor in Rat and Human Prostate Cancers and Benign Prostate Hyperplasia," Prostate, 14:191-208 (1989).
H.R. Habibi et al., "Characterization of Gonadotropin-Releasing Hormone (GnRH) Binding to Pituitary Receptors in Goldfish," Biol. Reprod., 36:844-853 (1987).
H.R. Habibi et al., "Extrapituitary gonadotropin-releasing hormone (GnRH) binding sites in goldfish," Fish Physiol. Biochem., 11:43-49 (1993).
H.R. Habibi, et al. "Functional Relationship between Receptor Binding and Biological Activity for Analogs of Mammalian and Salmon Gonadotropin-Releasing Hormones in the Pituitary of Goldfish (Carassius auratus).sup.1," Biol. Repro. 40:1152-1161 (1989).
H.R. Habibi et al., "Activity of vertebrate gonadotropin-releasing hormones and analogs with variant amino acid residues in positions 5, 7 and 8 in the goldfish pituitary," Regulatory Peptides, 37:271-284 (1992).
H.R. Habibi et al., "GnRH Binding To Human Hepato-Carcinoma Derived Cell Line, HEPG2: Is This An Evolutinary Primitive Feature?," XII Int'l. Congress of Compar. Endocrinol., Toronto A-61 (1993).
D. Heber, et al., "GnRH membrane binding: identification, specificity, and quantification in nonpituitary tissues," Am. J. Phys. 235:E227-E230 (1978).
Mc Pherson, "Analysis of Radioligand Binding Experiments," J. Pharmacol. Methods, 14:213-228 (1985).
R. Millar et al., "Chimeric Analogues of Vertebrate Gonadotropin-releasing Hormones Comprising Substitutions of the Variant Amino Acids in Positions 5, 7, and 8," J. Biol. Chem., 264:21007-21013 (1989).
W. Miller et al., "Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist," Nature, 313:231-233 (1992).
S. Milovanovic et al., "Inhibition of Growth of PC-82 Human Prostate Cancer Line Xenografts in Nude Mice by Bombesin Antagonist RC-3095 or Combination Somatostatin Analog RC-160," The Prostate, 20:269-280 (1992).
Munson et al., "LIGAND: A Versatile, Computerized Approach for Characterization of Ligand-Binding Systems," Anal. Biochem., 107:220-239 (1980).
H. Nakabayashi et al., "Growth of Human Hepatoma Cell Lines with Differentiated Functions in Chemically Defined Medium," Cancer Research 42:3858-3863 (1982).
D. Patel et al., "Metabolism Of A Novel Antitumor Agent, Crisnatol, By A Human Hepatoma Cell Line, Hep G2, and Hepatic Microsomes," Biochem. Pharmacol., 42:337-346 (1991).
D. Pati et al., "Characterization of gonadotropin-releasing hormone receptors in goldfish ovary: variation during follicular development,", Am. J. Physiol., 264:R227-R234 (1993).
T. Redding et al., "Sustained Release Formulations of Luteinizing Hormone-releasing Hormone Antagonist SB-75 Inhibit Proliferation and Enhance Apoptotic Cell Death of Human Prostate Carcinoma (PC-82) in Male Nude Mice.sup.1," Cancer Research 52:2538-2544 (1992).
T. Reissmann et al., "Treatment of experimental DMBA induced mammary carcinoma with Cetrorelix (SB-75): a potent antagonist of luteinizing hormone-releasing hormone," J Cancer Res. Oncol. 118:44-49 (1992).
A. Schally et al., "Antitumor Effects of Analogs of LH-RH And Somatostatin: Experimental And Clinical Studies," J. Steroid Biochem. Mol. Biol., 37:1061-1067 (1990).
T. Segal-Abramson et al., "Guanine nucleotide modulation of high affinity gonadotropin-releasing hormone receptors in rat mammary tumors," Mol. Cell. Endocrinol., 85:109-116 (1992).
S. Varma, et al. "Human Splenocytes Secrete LHRH, Which Inhibits Lymphocyte Proliferation," Prog. in NeuroEndocrinImmun. 5:187-191 (1992).
Walker et al., "Preliminary endocrinological evaluation of a sustained-release formulation of the LH-releasing hormone agonist D-Ser(BU.sup.t).sup.6 Azgly.sup.10 LHRH in premenopausal women with advanced breast cancer," J. Endocrinol., 111:349-353 (1986).
T. Yano, et al., "Inhibition of growth of MCF-7 MIII human breast carcinoma in nude mice by treatment with agonists or antagonists of LH-RH," Breast Cancer Research and Treatment, 21:35-45 (1992).
Zar, "Multiple Comparisons," Biostatistical Analysis, Prentice Hall, Inc., New Jersey, Ed. 2, 186-190 (1984).

Affiliated with

Also associated with

Rating

Inhibition of liver cancer by the use of GnRH and GnRH analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of liver cancer by the use of GnRH and GnRH analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of liver cancer by the use of GnRH and GnRH analogs will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1459786